Related Experiment Video
Updated: Jun 11, 2026

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency
Tamir Biezuner1, Yardena Brilon1, Asaf Ben Arye2
1Department of Immunology, Weizmann Institute of Science, Rehovot 761001, Israel.
NAR Genomics and Bioinformatics
|February 14, 2022
Summary
Molecular Inversion Probes (MIP) technology offers cost-effective targeted sequencing. Enhancements in biochemistry and machine learning significantly improve variant detection, especially for low-frequency variants, making MIPs a faster, more accurate diagnostic tool.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Deep targeted sequencing is crucial but limited by cost and complexity.
- Molecular Inversion Probes (MIP) offer scalability but face performance challenges, particularly in GC-rich regions and low variant allele frequencies.
Purpose of the Study:
- To enhance the performance and clinical applicability of MIP technology.
- To improve the detection of low-frequency variants using MIPs.
- To reduce the turnaround time and increase the efficiency of MIP-based sequencing.
Main Methods:
- Sequenced a large cohort (n=4417) using a 616-MIP panel at high depth.
- Developed and validated a statistical model for low variant allele frequency detection using machine learning.
- Implemented a biochemically modified MIP protocol and validated with amplicon sequencing.
- Assessed performance with a larger panel of 8349 genomic targets.
Main Results:
- Machine learning tools significantly improved precision for detecting variants with VAF > 0.005 (10-56.25%, P < 0.0004).
- The new MIP protocol improved uniformity, GC-rich region coverage, and achieved 95% on-target reads.
- Turnaround time was reduced to approximately 4 hours.
- Enhanced performance was demonstrated on a large panel of 8349 targets.
Conclusions:
- The study presents a significantly enhanced MIP targeted sequencing approach.
- Improvements in variant detection and overall performance pave the way for clinical diagnostics.
- The optimized MIP technology is positioned as an ultrafast, cost-effective tool for research and clinical applications.

